Journal Club Archive, 2015-2016 (Interventional Cardiology Fellowship)

submenu

Date links open recordings of combined article presentations, which redirect to Vimeo.

Article links will open journal articles for authorized users.

* * *

Online Article Access

PubMed ( National Library of Medicine )


10 June 2016
No Journal Club
Interventional M & M followed by seminar


27 May 2016

"Impact of the timing of metoprolol administration during STEMI on infarct size and ventricular function"
Garcia-Ruiz JM, Fernandez-Jimenez R, Garcia-Alvarez A et al.
JACC 2016;67:2093-2104


13 May 2016
No Journal Club
Angio review followed by seminar


6 May 2016

"Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers in myocardial-infarction patients with renal dysfunction"

Evans M, Carrero JJ, Szummer K et al.
JACC 2016;67:1687-1697

"Bicuspid aortic-valve stenosis: Favorable early outcomes with a next-generation transcatheter heart valve in a multicenter study"
Perlman GY, Blanke P, Dvir D et al.
JACC Cardiovasc Interv 2016;9:817-824

"Appropriate-use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention"
Desai NR, Bradley SM, Parzynski CS et al.
JAMA 2015;314:2045-2053


29 April 2016

"Immediate vs. delayed invasive intervention for non-STEMI patients: The RIDDLE-NSTEMI study"
Milosevic A, Vasiljevic-Pokrajcic Z, Milasinovic D et al.
JACC Cardiovasc Interv 2016;28:541-549

"Optimal strategy for provisional side-branch intervention in coronary bifurcation lesions: 3-year outcomes of the SMART-STRATEGY randomized trial"
Song YB, Park TK, Hahn JY et al.
JACC Cardiovasc Interv 2016;9:517-526


4 March 2016

"Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: A report from the CathPCI registry"
Wayangankar SA, Bangalore S, McCoy LA et al.
JACC Cardiovasc Interv 2016;9:341-351


26 February 2016

"Left-main stenting in comparison with surgical revascularization: 10-year outcomes of the (Left Main Coronary-Artery Stenting) LE MANS trial"
Buszman PE, Buszman PP, Banasiewicz-Szkrobka I et al.
JACC Cardiovasc Interv 2016;9:318-327


5 February 2016

"Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon-expandable transcatheter heart valve"
Husser O, Pellegrini C, Kessler T et al.
JACC Cardiovasc Interv 2016;9:244-254


29 January 2016

Part 1 of 2
Part 2 of 2

"Cyclosporine A in reperfused myocardial infarction: The multicenter, controlled, open-label CYCLE trial"
Ottani F, Latini R, Staszewsky L et al. (for the CYCLE investigators)
JACC 2016;67:365-374

"Effect of platelet inhibition with cangrelor during PCI on ischemic events"
Bhatt DL, Stone GW, Mahaffey KW et al. (for the CHAMPION PHOENIX investigators)
NEJM 2013;368:1303-1313


22 January 2016

"Single-staged compared with multi-staged PCI in multivessel NSTEMI patients: The SMILE trial"
Sardella G, Lucisano L, Garbo R et al.
JACC 2016;67:264-272


15 January 2016

"Prevention of contrast-induced nephropathy by central venous pressure-guided fluid administration in chronic kidney disease and congestive heart-failure patients"
Qian G, Fu Z, Guo J et al.
JACC Cardiovasc Interv 2016;9:89-96


8 January 2016

"The benefits conferred by radial access for cardiac catheterization are offset by a paradoxical increase in the rate of vascular-access site complications with femoral access: The Campeau radial paradox"
Azzalini L, Tosin K, Chabot-Blanchet M et al.
JACC Cardiovasc Interv 2015;8:1854-1864

"Transfemoral implantation of a fully repositionable and retrievable transcatheter valve for noncalcified pure aortic regurgitation"
Schofer J, Nietlispach F, Bijuklic K et al.
JACC Cardiovasc Interv 2015;8:1842-1849


18 December 2015

"Comparison of stent expansion guided by optical coherence tomography vs. intravascular ultrasound: The ILUMIEN II study (observational study of optical coherence tomography [OCT] in patients undergoing fractional flow reserve [FFR] and percutaneous coronary intervention)"
Maehara A, Ben-Yehuda O, Ali Z et al.
JACC Cardiovasc Interv 2015;8:1704-1714

"Long-term outcomes after treatment with a paclitaxel-coated balloon vs. balloon angioplasty: Insights from the PEPCAD-DES study (treatment of drug-eluting stent [DES] in-stent restenosis with SeQuent Please paclitaxel-coated percutaneous transluminal coronary angioplasty [PTCA] catheter)"
Rittger H, Waliszewski M, Brachmann J et al.
JACC Cardiovasc Interv 2015;8:1695-1700

"Everolimus-eluting bioresorbable scaffolds for coronary-artery disease"
Ellis SG, Kereiakes DJ, Metzger DC et al. (for the ABSORB III investigators)
NEJM 2015;373:1905-1915


11 December 2015
No Journal Club
Angio review followed by seminar


4 December 2015
No Journal Club
Seminar followed by related case presentation


20 November 2015

"Predicting the presence of an acute coronary lesion among patients resuscitated from cardiac arrest"
Waldo SW, Chang L, Strom JB et al.
Circ Cardiovasc Interv 2015;8:PMID: 26453684

"Impact of aortic-valve stenosis on coronary hemdynamics and the instantaneous effect of transcatheter aortic-valve implantation"
Wiegerinck EM, van de Hoef TP, Rolandi MC et al.
Circ Cardiovasc Interv 2015;8:PMID: 26245891

"A strategy of underexpansion and ad hoc post-dilation of balloon-expandable transcatheter aortic valves in patients at risk of annular injury: Favorable mid-term outcomes"
Tan JS, Leipsic J, Perlman G et al.
JACC Cardiovasc Interv 2015;8:1727-1732


13 November 2015
No Journal Club
Angio review followed by seminar


6 November 2015

"Final 3-year outcome of a randomized trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: NOBORI biolimus-eluting vs. XIENCE/PROMUS everolimus-eluting stent trial"
Naztsuaki M, Kozuma K, Morimoto T et al.
Circ Cardiovasc Interv 2015;8:PMID 26446596

"Outcomes after thrombus aspiration for ST-elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial"
Jolly SS, Cairns JA, Yusuf S et al.
Lancet 2015;Oct 12:PMID: 26474811

"Polymer-free drug-coated coronary stents in patients at high bleeding risk"
Urban P, Meredith IT, Abizaid A et al. (for the LEADERS FREE investigators)
NEJM 2015;Oct 14:PMID: 26466021 (e-pub ahead of print)


30 October 2015

"Complete vs. culprit-only revascularization for patients with multi-vessel disease undergoing primary percutaneous coronary intervention: An updated meta-analysis of randomized trials"
Elgendy IY, Wen X, Mahmoud A et al.
Catheter Cardiovasc Interv 2015;PMID: 26524970 (e-pub ahead of print)

presented with

"Complete vs. culprit-only revascularization in patients with multi-vessel disease undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials"
Elgendy IY, Huo T, Mahmoud A et al.
Int J Cardiol 2015;186:98-103

* * *

"A randomized trial of deferred stenting vs. immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI)"
Carrick D, Oldroyd KG, McEntegart M et al.
JACC 2014;63:2088-2098

"Paclitaxel-eluting vs. everolimus-eluting coronary stents in diabetes"
Kaul U, Bangalore S, Seth A et al. (for the TUXEDO-India investigators)
NEJM 2015;373:1709-1719


23 October 2015
No Journal Club
Seminar only


16 October 2015
No Journal Club
Two seminar presentations


9 October 2015
No Journal Club
Angio review followed by seminar


2 October 2015

"Percutaneous coronary intervention at centers with and without on-site surgical backup: An updated meta-analysis of 23 studies"
Lee JM, Hwang D, Park J et al.
Circulation 2015;132:388-401

"Clinical and functional outcomes associated with myocardial injury after transfemoral and transapical transcatheter aortic-valve replacement: A subanalysis from the PARTNER trial (Placement of Aortic Transcatheter Valves)"
Paradis JM, Maniar HS, Lasala JM et al.
JACC Cardiovasc Interv 2015;8.1468-1479

"Intracoronary adenosine: Dose-response relationship with hyperemia"
Adjedj J, Toth GG, Johnson NP et al.JACC Cardiovasc Interv 2015;8:1422-1430


18 September 2015

"Increased risk of cerebral embolization after implantation of a balloon-expandable aortic valve without prior balloon valvuloplasty"
Bijuklic K, Haselbach T, Witt J et al.
JACC Cardiovasc Interv 2015 Sep 9;PMID: 26386760 (e-pub ahead of print)

"Long-term clinical outcomes of final kissing ballooning in coronary bifurcation lesions treated with the 1-stent technique: Results from the COBIS II registry (Korean CORonary BIfurcation Stenting Registry)"
Yu CW, Yang JH, Song YB et al.
JACC Cardiovasc Interv 2015;8:1297-1307


11 September 2015
No Journal Club
Angio review followed by CCL M & M conference

 * * *

7:00-8:00  Revascularization Rounds
Monthly angio review with University of Minnesota Heart Care interventional cardiologists.
Fellows, please have your cases approved in advance by Dr. Raveendran.

University Campus: 130 KE
Fairview Southdale: Heart Clinic Boardroom (W-350)
Fairview Ridges: CV Consultation Room

Internet: http://z.umn.edu/interventionalvr
Videoconferencing: ivr@vgconnectus.com
Phone: (855) 693-0288, Call ID: 298516695

* * *

8:15-9:30  CCL M & M Conference
Bridges Conference Room (not the Bridges Boardroom)
UMMC, 8th Floor (inside the cafeteria)


4 September 2015

"Predicting survival after ECMO for refractory cardiogenic shock: The survival after veno-arterial-ECMO (SAVE)-score"
Schmidt M, Burrell A, Roberts L et al.
Eur Heart J 2015;36:2246-2256

"Fractional flow reserve vs. angiography for guidance of PCI in patients with multivessel coronary-artery disease (FAME): 5-year follow-up of a randomised controlled trial"
van Nunen LX, Zimmermann FM, Tonino PA et al.
Lancet 2015 Aug 28;PMID: 26333474 (e-pub ahead of print)

"Bivalirudin or unfractionated heparin in acute coronary syndromes"
Valgimigli M, Frigoli E, Leonardi S et al.
NEJM 2015 Sept 1;PMID: 26324049 (e-pub ahead of print)


28 August 2015

"Use and outcomes of triple therapy among older patients with acute myocardial infarction and atrial fibrillation"
Hess CN, Peterson ED, Peng SA et al.
JACC 2015;66:616-627

"Effect of vascular-access site choice on radiation exposure during coronary angiography: The REVERE trial (Randomized Evaluation of Vascular-Entry Site and Radiation Exposure)"
Pancholy SB, Joshi P, Shah S et al.
JACC Cardiovasc Interv 2015;8:1189-1196

"Safety of prasugrel loading doses in patients pre-loaded with clopidogrel in the setting of primary precutaneous coronary intervention: Results of a nonrandomized observational study"
Raber L, Klingenberg R, Heg D et al.
JACC Cardiovasc Interv 2015;8:1064-1074


21 August 2015
No Journal Club
Seminar followed by equipment set-up and demonstrations in the cardiac catheterization laboratory with ACIST, St. Jude Medical, and Volcano


14 August 2015
No Journal Club
Angio review followed by seminar


7 August 2015
No Journal Club
Seminar followed by equipment set-up and demonstrations in the cardiac catheterization laboratory: Boston Scientific and CSI (Diamondback)


31 July 2015

"Percutaneous coronary intervention at centers with and without onsite surgical backup: An updated meta-analysis of 23 studies"
Lee JM, Hwang D, Park J et al.
Circulation 2015;July 7:115.016137 (e-pub ahead of print)

combined with

"Outcomes of percutaneous coronary intervention performed at offsite vs. onsite surgical centers in the United Kingdom"
Garg S, Anderson SG, Oldroyd K et al.
JACC 2015;66:363-372

 * * *

"2-year outcomes in patients undergoing surgical or self-expanding transcatheter aortic-valve replacement"

Reardon MJ, Adams DH, Kleiman NS et al.
JACC 2015;66:113-121

"Perioperative results and complications in 15,964 transcatheter aortic-valve replacements: Prospective data from the GARY registry"
Walther T, Hamm CW, Schuler G et al. (for the GARY Executive Board)
JACC 2015;65:2173-2180


24 July 2015

"Randomized trial of stents vs. bypass surgery for left-main coronary-artery disease: 5-year outcomes of the PRECOMBAT study"
Ahn JM, Roh JH, Kim YH et al.
JACC 2015;65:2198-2206


17 July 2015

"A prospective randomized trial of drug-eluting balloons vs. everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: The RIBS IV randomized clinical trial"
Alfonso F, Perez-Vizcayno MJ, Cardenas A et al.
JACC 2015;66:23-33